Evolus Inc (EOLS)
Healthcare
Drug Manufacturers - Specialty & Generic
5.80 $
-2.8%
vs. previous close
Closing price · As of: 31. Jul 2026
Who owns Evolus Inc (EOLS)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 76.0% of the shares are freely tradable; institutional investors hold 70.1%.
Ownership Structure
Institutional ownership
Share of the stock held by institutional investors (funds, banks, insurers) according to regulatory filings.
70.1%
Insiders
Share of the stock held by the executives, founders and major shareholders of the company itself.
14.7%
Float
Share of stock freely tradable on the market — not locked up in the hands of founders, insiders, or major shareholders.
76.0%
Short % of float
Shares sold short as a percentage of the freely tradable float — high values signal many bets on falling prices.
9.1%
Shares Outstanding
Total number of shares issued. Price times share count gives market cap.
66Mio.
Largest Shareholders
Institutions
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| Nantahala Capital Management, LLC | 9.68 | 6,376,857 | +9.6 | 03/31/2026 |
| BlackRock Inc | 6.51 | 4,290,383 | +4.8 | 03/31/2026 |
| Vanguard Group Inc | 5.07 | 3,341,804 | -2.5 | 12/31/2025 |
| BRAIDWELL LP | 4.72 | 3,105,209 | +0.0 | 03/31/2026 |
| Frazier Life Sciences Management, L.P. | 3.99 | 2,630,665 | +0.0 | 03/31/2026 |
| Vanguard Capital Management, LLC | 3.75 | 2,470,408 | +0.0 | 03/31/2026 |
| Soleus Capital Management, L.P. | 3.41 | 2,245,360 | +109.8 | 03/31/2026 |
| Stonepine Capital Management Llc | 2.67 | 1,759,091 | +7.8 | 03/31/2026 |
| Millennium Management LLC | 2.22 | 1,461,159 | -30.2 | 03/31/2026 |
Funds
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| Vanguard Total Stock Mkt Idx Inv | 2.53 | 1,665,893 | +0.0 | 04/30/2026 |
Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.
Data as of: July 31, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.